Skip to main content
PMC home page
International Orthopaedics logoLink to International Orthopaedics
. 2004 Dec 30;29(1):1–5. doi: 10.1007/s00264-004-0608-4

Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip

Christian E Berger 1,✉, Andreas Kröner 1, Helmar Stiegler 1, Thomas Leitha 2, Alfred Engel 1
PMCID: PMC3456947  PMID: 15625614

Abstract

We compared type I collagen degradation using serum cross-linking C-terminal telopeptide (ICTP) in 18 patients with rapidly destructive osteoarthrosis and in 20 patients with slowly progressive osteoarthrosis of the hip. The diagnosis was established by clinical examination and radiographic evaluation. Total hip arthroplasty was performed in all patients. Serum levels of ICTP, bone-specific alkaline phosphatase, osteocalcin and N-terminal propeptide were studied. Patients with rapidly destructive osteoarthrosis had higher mean (SD) serum ICTP levels than patients with slowly progressive osteoarthrosis [13.2 (5.6) versus 3.7 ng/ml (1.4), p=0.001] whereas no significant difference of all other markers was seen between the groups. Elevation of ICTP levels correlated significantly with decreased joint-space width assessed by radiographs of the hip (p=0.01). Our data suggest that rapidly destructive hip osteoarthrosis is associated with elevated serum ICTP levels, reflecting increased collagen type I degradation.

Full Text

The Full Text of this article is available as a PDF (103.3 KB).

References

  • 1.Berger CE, Kröner A, Thomas E, Kristen KH, Ogris E, Engel A. Comparison of biochemical markers of bone metabolism in serum and distal femur aspirates. Clin Orthop. 2002;395:174–179. doi: 10.1097/00003086-200202000-00019. [DOI] [PubMed] [Google Scholar]
  • 2.Boutry N, Paul C, Leroy X, Fredoux D, Migaud H, Cotton A. Rapidly destructive osteoarthritis of the hip: MR imaging findings. Am J Roentgenol. 2002;79:657–663. doi: 10.2214/ajr.179.3.1790657. [DOI] [PubMed] [Google Scholar]
  • 3.Chevalier X, Conrozier T, Gehrmann M, Claudepierre P, Mathieu P, Unger S, Vignon E. Tissue inhibitor of metalloproteinase-1 (TIMP-1) serum levels may predict progression of hip osteoarthritis. Osteoarthr Cartil. 2001;9:300–307. doi: 10.1053/joca.2000.0389. [DOI] [PubMed] [Google Scholar]
  • 4.Conrozier T, Chappuis-Cellier C, Richard M, Mathieu P, Richard S, Vignon E. Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis. Rev Rhum (Engl Ed) 1998;65:759–765. [PubMed] [Google Scholar]
  • 5.Delmas PD. Biochemical markers of bone turnover in Paget’s disease of bone. J Bone Miner Res. 1999;14(Suppl 2):66–69. doi: 10.1002/jbmr.5650140213. [DOI] [PubMed] [Google Scholar]
  • 6.Eriksen E, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of Type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J Bone Miner Res. 1993;8:127–132. doi: 10.1002/jbmr.5650080202. [DOI] [PubMed] [Google Scholar]
  • 7.Flik K, Vargas JH., III Rapidly destructive hip disease: a case report and review of the literature. Am J Orthop. 2001;30:549–552. [PubMed] [Google Scholar]
  • 8.Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas PD, Vignon E. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis. 2003;62:939–943. doi: 10.1136/ard.62.10.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Bort O, Qvist P, Delmas PD, Foged NT, Delaisse JM. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res. 2003;18:859–867. doi: 10.1359/jbmr.2003.18.5.859. [DOI] [PubMed] [Google Scholar]
  • 10.Hakala M, Aman S, Luukkainen R, Risteli L, Kauppi M, Nieminen P, Risteli J. Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis. 1995;54:886–890. doi: 10.1136/ard.54.11.886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new model of evaluation. J Bone Joint Surg Am. 1969;51:737–755. [PubMed] [Google Scholar]
  • 12.Komiya S, Inoue A, Sasguri Y, Minamitani K, Morimatsu M. Rapidly destructive arthropathy of the hip. Studies on bone resorptive factors in joint fluid with a theory of pathogenesis. Clin Orthop. 1992;284:273–282. [PubMed] [Google Scholar]
  • 13.Kotaniemi A, Risteli J, Aho K, Hakala M. Increased type I collagen degradation correlates with disease activity in reactive arthritis. Clin Exp Rheumatol. 2003;21:95–98. [PubMed] [Google Scholar]
  • 14.Laroche M, Moineuse C, Durroux R, Mazieres B, Puget J. Can ischemic hip disease cause rapidly destructive hip osteoarthritis? Jt Bone Spine. 2002;69:76–80. doi: 10.1016/S1297-319X(01)00346-3. [DOI] [PubMed] [Google Scholar]
  • 15.Lequesne M. Rapidly progressive destructive diseases of the hip. Ann Radioelectr (Paris) 1993;36:62–64. [PubMed] [Google Scholar]
  • 16.Matsumoto F, Uzuki M, Kaneko C, Rikimaru A, Kokubun S, Sawai S. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analysed by a immunohistochemical study. Ryumachi. 1997;37:688–695. [PubMed] [Google Scholar]
  • 17.Meneghello A, Franceschi E. Destructive arthrosis of the hip. Natural history, pathogenesis and radiographic features. Radiol Med (Torino) 1996;92:186–192. [PubMed] [Google Scholar]
  • 18.Piaggesi A, Rizzo L, Golia F, Costi D, Baccetti F, Ciacco S, Gregori S, Vignali E, Trippi D, Zampa V, Marcocci C, Prato S. Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot. Diabetes Res Clin Pract. 2002;58:1–9. doi: 10.1016/s0168-8227(02)00097-9. [DOI] [PubMed] [Google Scholar]
  • 19.Postel M, Kerboull M. Total prosthetic replacement in rapidly destructive arthrosis of the hip. Clin Orthop. 1970;72:138–144. [PubMed] [Google Scholar]
  • 20.Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C. Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone. 2002;31:57–61. doi: 10.1016/s8756-3282(02)00791-3. [DOI] [PubMed] [Google Scholar]
  • 21.Rosenberg ZS, Shankman S, Steiner GC, Kastenbaum DK, Norman S, Lazansky MG. Rapid destructive osteoarthritis: clinical, radiographic, and pathologic features. Radiology. 1992;182:213–216. doi: 10.1148/radiology.182.1.1727284. [DOI] [PubMed] [Google Scholar]
  • 22.Ryu KN, Kim EJ, Yoo MC, Park YK, Sartoris DJ, Resnick D. Ischemic necrosis of the entire femoral head and rapidly destructive hip disease: potential causative relationship. Skelet Radiol. 1997;41:311–313. doi: 10.1007/s002560050210. [DOI] [PubMed] [Google Scholar]
  • 23.Schneider U, Schmidt-Rohlfing B, Knopf U, Breusch SJ. Effects upon bone metabolism following total hip and total knee arthroplasty. Pathobiology. 2002;70:26–33. doi: 10.1159/000065999. [DOI] [PubMed] [Google Scholar]
  • 24.Wilkinson JM, Hamer AJ, Rogers A, Stockley I, Eastell R. Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplasty. J Orthop Res. 2003;21:691–696. doi: 10.1016/S0736-0266(02)00237-1. [DOI] [PubMed] [Google Scholar]

Articles from International Orthopaedics are provided here courtesy of Springer-Verlag

RESOURCES